Samsung BioLogics is headquartered in South Korea and manufactures biopharmaceutical products. Founded in 2011, the company entered the biopharmaceutical industry during a time in which the industry was facing significant change. The global availability and capacity for biologics manufacturing is decreasing, and new, innovative types of medicines are being developed to help millions suffering from devastating diseases. Given the nature of their business, a compliance focus has become very important to the organization and arguably more than other industries. Pharmaceutical drugs have the power to save lives, but when used inappropriately, can also be harmful, making it important to properly govern all aspects of the business.

Read more at Samsung BioLogics Builds Identity Governance from the Ground Up